Breast Cancer: Rank Ligand Inhibition

Breast Care - Switzerland
doi 10.1159/000321122
Full Text
Abstract

Available in full text

Categories
SurgeryOncology
Date
Authors
Publisher

S. Karger AG

Related search

The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab

Oncologist
Cancer ResearchMedicineOncology
2011English

RANK-ligand (RANKL) Expression in Young Breast Cancer Patients and During Pregnancy

Breast Cancer Research
Cancer ResearchOncology
2015English

RANKL/RANK: From Bone Loss to the Prevention of Breast Cancer

Open Biology
BiochemistryImmunologyGeneticsMolecular BiologyNeuroscience
2016English

RANK, RANKL and OPG Expression in Breast Cancer – Influence on Osseous Metastasis

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2012English

ERRα Promotes Breast Cancer Cell Dissemination to Bone by Increasing RANK Expression in Primary Breast Tumors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

RANK Ligand and the Regulation of Skeletal Remodeling

Journal of Clinical Investigation
Medicine
2003English

Antibody-Nkg2d Ligand (Rae-1Beta) Fusion Protein for Breast Cancer Therapy

2005English

RANKL/RANK/OPG System Beyond Bone Remodeling: Involvement in Breast Cancer and Clinical Perspectives

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Cross-Kingdom Inhibition of Breast Cancer Growth by Plant miR159

Cell Research
Cell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy